Observational study of the safety of an ultra-rush sublingual immunotherapy regimen to treat rhinitis due to house dust mites

International Archives of Allergy and Immunology

Volumn 154, Issue 1, 2010, Pages 69-75

  Roger, Albert ^a   Justicia, José Luis ^c   Navarro, Luis Ángel ^b   Eseverri, José Luis ^d   Ferrès, Jeroni ^e   Malet, Alfons ^f   Alvà, Víctor ^c  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b HOSPITAL LLUÍS ALCANYÍS   (Spain)

^c Stallergens Ibérica S A   (Spain)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^e Hospital Sant Pau   (Spain)

^f Al lergo Centre   (Spain)

Author keywords

Asthma; Dermatophagoides; Rhinitis; Sublingual immunotherapy; Ultra rush

Indexed keywords

HOUSE DUST ALLERGEN; STALORAL 300; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; ASTHMA; BURNING MOUTH SYNDROME; CHILD; DERMATOPHAGOIDES; DIZZINESS; DRUG DOSE INCREASE; DRUG MEGADOSE; DYSPNEA; EAR DISEASE; EPIGASTRIC PAIN; FEMALE; FLATULENCE; GASTROINTESTINAL PAIN; HOUSE DUST ALLERGY; HUMAN; HYPERPIGMENTATION; IMMUNOTHERAPY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALAISE; MALE; MOUTH EDEMA; NAUSEA; NOSE DISEASE; OBSERVATIONAL STUDY; PHARYNX DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURITUS; RASH; RHINITIS; SCHOOL CHILD; SPAIN; SPIROMETRY; VAGINA DISCHARGE; VOMITING;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; CHILD; CHILD, PRESCHOOL; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; MALE; MIDDLE AGED; RHINITIS, ALLERGIC, PERENNIAL; SPAIN; YOUNG ADULT;

EID: 77954875767     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319211     Document Type: Article

References (24)

1. Amin HS, Liss GM, Bernstein DI: Evaluation of near-fatal reactions to allergen immunotherapy injections. J Allergy Clin Immunol 2006; 117: 169-175.
2. Canonica GW, Passalacqua G: Noninjection routes for immunotherapy. J Allergy Clin Immunol 2003; 111: 437-448.
3. Andre C, Vatrinet C, Galvain S, Carat F, Sicard H: Safety of sublingual-swallow immunotherapy in children and adults. Int Arch Allergy Immunol 2000; 121: 229-234.
4. Wilson DR, Lima MT, Durham SR: Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005; 60: 4-12.
5. Calamita Z, Saconato H, Pela AB, Atallah AN: Efficacy of sublingual immunotherapy in asthma: systematic review of randomizedclinical trials using the cochrane collaboration method. Allergy 2006; 61: 1162-1172.
6. Bousquet J, Van Cauwenberge P, Khaltaev N: Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108:S147-S334.
7. Khinchi MS, Poulsen LK, Carat F, Andre C, Hansen AB, Malling HJ: Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study. Allergy 2004; 59: 45-53. (Pubitemid 38167951)
8. Bousquet J: Sublingual immunotherapy: validated!! Allergy 2006; 61(suppl 81):S5-S6.
9. Vervloet D, Birnbaum J, Laurent P, Hugues B, Fardeau MF, Massabie-Bouchat YP, Aferiat-Derome A, Andre C: Safety and efficacy of Juniperus ashei sublingual-swallow ultrarush pollen immunotherapy in cypress rhinoconjunctivitis: a double-blind, placebocontrolled study. Int Arch Allergy Immunol 2007; 142: 239-246.
10. Ott H, Sieber J, Brehler R, Folster-Holst R, Kapp A, Klimek L, Pfaar O, Merk H: Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study. Allergy 2009; 64: 179-186.
11. Stelmach I, Kaczmarek-Wozniak J, Majak P, Olszowiec-Chlebna M, Jerzynska J: Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen. Clin Exp Allergy 2009; 39: 401-408.
12. Tripodi S, Di Rienzo Businco A, Benincori N, Scala G, Pingitore G: Safety and tolerability of ultra-rush induction, less than one hour, of sublingual immunotherapy in children. Int Arch Allergy Immunol 2006; 139: 149-152.
13. Gammeri E, Arena A, D'Anneo R, La Grutta S: Safety and tolerability of ultra-rush (20 min) sublingual immunotherapy in patients with allergic rhinitis and/or asthma. Allergol Immunopathol (Madr) 2005; 33: 221-223. (Pubitemid 41473119)
14. Cox LS, Larenas Linnemann D, Nolte H, Weldon D, Finegold I, Nelson HS: Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 2006; 117: 1021-1035.
15. Malling HJ, Weeke B: Position paper: immunotherapy. Allergy 1993; 48(suppl 14):9-35.
16. Rodriguez F, Boquete M, Ibanez MD, de la Torre-Martinez F, Tabar AI: Once daily sublingual immunotherapy without updosing: a new treatment schedule. Int Arch Allergy Immunol 2006; 140: 321-326.
17. Gidaro GB, Marcucci F, Sensi L, Incorvaia C, Frati F, Ciprandi G: The safety of sublingualswallow immunotherapy: an analysis of published studies. Clin Exp Allergy 2005; 35: 565-571. (Pubitemid 40769278)
18. Rossi RE, Monasterolo G: A pilot study of feasibility of ultra-rush (20-25 min) sublingual-swallow immunotherapy in 679 patients (699 sessions) with allergic rhinitis and/or asthma. Int J Immunopathol Pharmacol 2005; 18: 277-285.
19. Seidenberg J, Pajno GB, Bauer CP, La Grutta S, Sieber J: Safety and tolerability of seasonal ultra-rush high-dose sublingual-swallow immunotherapy in allergic rhinitis to grass and tree pollens: an observational study in 193 children and adolescents. J Investig Allergol Clin Immunol 2009; 19: 125-131.
20. Blazowski L: Anaphylactic shock because of sublingual immunotherapy overdose during third year of maintenance dose. Allergy 2008; 63: 374.
21. Dunsky EH, Goldstein MF, Dvorin DJ, Belecanech GA: Anaphylaxis to sublingual immunotherapy. Allergy 2006; 61: 1235.
22. Sieber J, Merk HF: Tolerability and effectiveness of seasonal SLIT with ultra-rush titration: an open prospective observational study. XXIII Congress of the EAACI, 2004 (abstract book):140-141.
23. Merk HF, Sieber J: Safety of high-dose sublingual immunotherapy with ultra-rush titration: New follow-up data from a DBPC study in grass-pollen allergic patients. XXIII Congress of the EAACI, 2004 (abstract book): 4.
24. Abramson MJ, Puy RM, Weiner JM: Allergen immunotherapy for asthma. Cochrane Database Syst Rev 2000:CD001186.